Stock listing

Ibio, Inc.

Selected listing: 0JV0 · FWB · EUR · DE

Ibio, Inc. (Frankfurt:0JV0), Health Technology. Latest release Sep 16, 2026: Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement…

0JV0:FWBEURDEUpdated October 3, 2026

Ticker: Frankfurt:0JV0
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: Frankfurt
Currency: EUR

Latest news from Ibio, Inc.

Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)

September 16, 2026

iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference

September 1, 2026

iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

August 28, 2026

IntraBio’s Pivotal Phase III Trial in CACNA1A-Related Disorders Is Enrolling and Is Expected to Be Over-Enrolled and Complete Recruitment in October

August 19, 2026

ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman

August 10, 2026

All Ibio, Inc. news →

Research Ibio, Inc.

Ibio, Inc. company profile

View the public company page for Ibio, Inc. on 6ix.

Ibio, Inc. news

Read company news and market updates connected to Ibio, Inc..

Ibio, Inc. investor events

Find investor webinars, events, and replay context for Ibio, Inc..